Drugs Research Group

Substance misuse research within the Addictions Department is led by Professors John Strang and John Marsden.

They head a multidisciplinary team made up of academic researchers and clinical practitioners with backgrounds in social science, psychology and psychiatry.

Building upon a history of successful grant applications, we have secured funding for ongoing research in the UK from the National Institute for Health Research, the English Department of Health and the Medical Research Council.

Through our own high quality individual endeavours, and by working collaboratively with research leaders from other institutions, we continue to develop the UK’s evidence base on drug prevention and treatment, adding to our historical contributions towards drugs policy and current involvement in the development of clinical guidelines.

Members

John Cunningham

Chair in Addictions Treatment & Recovery Studies

Amir Englund

Research Fellow

Carol-Ann Getty

Postdoctoral Researcher

Gail Gilchrist

Professor in Addictions Healthcare Research

Nicola Metrebian

Senior Lecturer in Addiction Treatment Studies

Stephen Parkin

Research Fellow

Polly Radcliffe

Senior Research Fellow

Emmert Roberts

MRC Clinical Research Fellow

Clariza Saint George

PhD Student

Emma Smith

Research Associate

John Strang

Head of Department

Basak Tas

Research Fellow

Men, Substance Use and Relationships: A Bilateral Learning Alliance (England and Brazil)

This project is funded by the Economic and Social Research Council and led by Dr Gail Gilchrist at the National Centre for Addictions, King's College London.

The Stepping Stones Study

A longitudinal study aiming to understand how health and social care providers can best meet the needs of women who use drugs and the needs of their babies.

The cost-effectiveness of financial incentives to achieve heroin abstinence in individuals with heroin use disorder starting new treatment episodes: A cluster randomised controlled trial-based economic evaluation: Financial incentives for heroin abstinence
Shearer, J., Metrebian, N., Weaver, T., Goldsmith, K., Strang, J., Pilling, S., Mitcheson, L., Day, E., Dunn, J., Glasper, A., Akhtar, S., Bajaria, J., Charles, V., Desai, R., Haque, F., Little, N., McKechnie, H., Mosler, F., Mutz, J., Poovendran, D., & 1 othersByford, S., 22 Nov 2022, (Accepted/In press) In: Value in Health. Research output: Contribution to journal › Article › peer-review
Healthcare Practitioners Knowledge of Shoulder Injury Related to Vaccine Administration (SIRVA)
Mackenzie, L. J., Bousie, J. A., Newman, P., Waghorn, J., Cunningham, J. E. & Bushell, M-J. A., 23 Nov 2022, In: Vaccines. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.3390/vaccines10121991
Experience and response to a randomised controlled trial of extended-release injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone for opioid use disorder: protocol for a mixed-methods evaluation
Lowry, N., Cowden, F., Day, E., Gilvarry, E., Johnstone, S., Murray, R., Kelleher, M., Mitcheson, L. & Marsden, J., 21 Oct 2022, In: BMJ Open. 12, 10, p. e067194 e067194. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1136/bmjopen-2022-067194
Effects of cannabidiol and delta-9-tetrahydrocannabinol on plasma endocannabinoid levels in healthy volunteers: a randomised double-blind four-arm cross-over study
Chester, L., Englund, A., Chesney, E., Oliver, D., Wilson, J., Sovi, S., Dickens, A. M., Oresic, M., Linderman, T., Hodsoll, J., Minichino, A., Strang, J., Murray, R., Freeman, T. P. & McGuire, P., 10 Oct 2022, (Accepted/In press) In: Cannabis and cannabinoid research. Research output: Contribution to journal › Article › peer-review
Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England
Aldabergenov, D., Reynolds, L., Scott, J., Kelleher, MJ., Copeland, CS., Strang, J. & Kalk, NJ., 4 Oct 2022, (E-pub ahead of print) In: International Journal of Drug Policy. 103877. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1016/j.drugpo.2022.103877
The economic case for hospital discharge services for people experiencing homelessness in England: An in-depth analysis with different service configurations providing specialist care
Tinelli, M., Wittenberg, R., Cornes, M., Aldridge, R. W., Clark, M., Byng, R., Foster, G., Fuller, J., Hayward, A., Hewett, N., Kilmister, A., Manthorpe, J., Neale, J., Biswell, E. & Whiteford, M., 7 Oct 2022, In: Health and Social Care in the Community. p. 1-12 12 p. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/. , https://doi. org/10.1111/hsc.14057
The feasibility of delivering the ADVANCE digital intervention to reduce intimate partner abuse by men receiving substance use treatment: protocol for a non-randomised multi-centre feasibility study and embedded process evaluation
Gilchrist, G., Landau, S., Dheensa, S., Henderson, J., Johnson, A., Love, B., Potts, L., Radcliffe, P., Zenasni, Z., Parrott, S., Li, J., Thomson, K., Dwyer, G. J., Turner, R., Halliwell, G., Berbary, C., Bergman, C., Feder, G., Easton, C., Brooks, C. P., & 1 othersGilchrist, E., Dec 2022, In: Pilot and Feasibility Studies. 8, 1, 163. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1186/s40814-022-01116-x
The impact of the COVID-19 pandemic on addictive disorders—an update
Marsden, J., Brown, J., Clark, L., Cousijn, J., Hall, W., Hickman, M., Holmes, J., Humphreys, K., Jackson, S. E., Peacock, A. & Tucker, J., 1 Nov 2022, In: Addiction. 117, 11, p. 2762-2766 5 p. Research output: Contribution to journal › Editorial › peer-review. DOIs: https://doi.org/10.1111/add.16033
Extended-release pharmacotherapy for opioid use disorder (EXPO): protocol for an open-label randomised controlled trial of the effectiveness and cost-effectiveness of injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone
Marsden, J., Kelleher, M., Hoare, Z., Hughes, D., Bisla, J., Cape, A., Cowden, F., Day, E., Dewhurst, J., Evans, R., Hearn, A., Kelly, J., Lowry, N., McCusker, M., Murphy, C., Murray, R., Myton, T., Quarshie, S., Scott, G., Turner, S., & 4 othersVanderwaal, R., Wareham, A., Gilvarry, E. & Mitcheson, L., Dec 2022, In: Trials. 23, 1, 697. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1186/s13063-022-06595-0
Widening the Cracks: Unintended Harms of Excluding Individuals at Risk of Suicide from Broader Mental Health Research
Godinho, A., Schell, C. & Cunningham, J. A., 2022, (Accepted/In press) In: Crisis. Research output: Contribution to journal › Review article › peer-review. DOIs: https://doi.org/10.1027/0227-5910/a000872

View all publications

Drugs Research Group

Members

John Cunningham

Amir Englund

Carol-Ann Getty

Gail Gilchrist

Nicola Metrebian

Stephen Parkin

Polly Radcliffe

Emmert Roberts

Clariza Saint George

Emma Smith

John Strang

Basak Tas

Men, Substance Use and Relationships: A Bilateral Learning Alliance (England and Brazil)

The Stepping Stones Study

The cost-effectiveness of financial incentives to achieve heroin abstinence in individuals with heroin use disorder starting new treatment episodes: A cluster randomised controlled trial-based economic evaluation: Financial incentives for heroin abstinence

Healthcare Practitioners Knowledge of Shoulder Injury Related to Vaccine Administration (SIRVA)

Experience and response to a randomised controlled trial of extended-release injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone for opioid use disorder: protocol for a mixed-methods evaluation

Effects of cannabidiol and delta-9-tetrahydrocannabinol on plasma endocannabinoid levels in healthy volunteers: a randomised double-blind four-arm cross-over study

Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England

The economic case for hospital discharge services for people experiencing homelessness in England: An in-depth analysis with different service configurations providing specialist care

The feasibility of delivering the ADVANCE digital intervention to reduce intimate partner abuse by men receiving substance use treatment: protocol for a non-randomised multi-centre feasibility study and embedded process evaluation

The impact of the COVID-19 pandemic on addictive disorders—an update

Extended-release pharmacotherapy for opioid use disorder (EXPO): protocol for an open-label randomised controlled trial of the effectiveness and cost-effectiveness of injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone

Widening the Cracks: Unintended Harms of Excluding Individuals at Risk of Suicide from Broader Mental Health Research

Study at King’s

Information for

Facilities

Discover King’s

Contact us

Drugs Research Group

Members

Men, Substance Use and Relationships: A Bilateral Learning Alliance (England and Brazil)

The Stepping Stones Study

Faculties & departments